Drug delivery to a patient’s lung for disease treatment involves more than “simply” the performance of the drug delivery device; the mechanics of lung deposition in a patient’s lungs on each individual inhalation has a huge impact on the dose delivered.
Latest from the network
Looking for something specific?
Drug delivery to a patient’s lung for disease treatment involves more than “simply” the performance of the drug delivery device; the mechanics of lung deposition in a patient’s lungs on each individual inhalation has a huge impact on the dose delivered.
Watch Marshall Centre's guide to how risk management helps you and your organisation: https://lnkd.in/gGc7bQG
Several conspiracy theories have spread in recent weeks, including claims that COVID-19 is caused by electromagnetic waves from new 5G telephone masts, and that governments are deliberately creating panic in order to introduce tighter controls over their populations.
The UK Government has acted at pace to protect companies and jobs. So far around £6billion in grants from local authorities have reached small businesses. And the Job Retention Scheme started strongly on Monday, safeguarding nearly three million jobs, latest figures show.
RaDaR is designed to be complementary to tumor profiling assays including Inivata’s InVisionFirst®-Lung and will initially be used in a clinical trial setting for patients who have already received a cancer diagnosis.
Claire Vane of Integrated Resources writes: